Certified by Founder Lodge
Rampart Bioscience
United States - Delhi, California
START UP
1 Disclosed Funding Rounds $85,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 25 ,2023 | Series A | $85,000,000 |
OrbiMed
RA Capital Management, L.P.
HealthCap
Forbion
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Brevo | $582,532,500 | (Dec 5, 2025)
